<DOC>
	<DOCNO>NCT00620022</DOCNO>
	<brief_summary>This study compare effect indacaterol ( 300 μg daily [ od ] ) exercise endurance placebo patient moderate severe chronic obstructive pulmonary disease .</brief_summary>
	<brief_title>The Effect Indacaterol Exercise Endurance Patients With Moderate Severe Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Male female adult age ≥ 40 year , sign informed consent form prior initiation studyrelated procedure . Cooperative outpatient diagnosis moderate severe chronic obstructive pulmonary disease ( COPD ) , classify GOLD Guidelines ( 2006 ) , : Smoking history least 20 pack year . Postbronchodilator force expiratory volume 1 second ( FEV1 ) &lt; 80 % ≥ 30 % predict normal value . Postbronchodilator FEV1/forced vital capacity ( FVC ) &lt; 70 % . Pregnant nursing ( lactate ) woman . Women childbearing potential . Patients hospitalize COPD exacerbation 6 week prior screen runin period . Patients require oxygen therapy experience oxygen desaturation &lt; 80 % cycle exercise room air . Patients Wmax value &lt; 20 W ( determine incremental cycle endurance test ) screening . Patients respiratory tract infection within 6 week prior screen . Patients contraindication cardiopulmonary exercise testing . Patients concomitant pulmonary disease . Patients history ( include screen visit ) asthma . Patients diabetes Type I uncontrolled diabetes Type II . Any patient lung cancer history lung cancer . Any patient active cancer history cancer le 5 year disease free survival time . Patients history long QT syndrome whose QTc interval ( Bazett 's ) measure collection inform consent visit ( Visit 1 ) randomization prolong . Patients vaccinate live attenuate vaccine within 30 day prior screen runin period . Patients unable successfully use dry powder inhaler device , meter dose inhaler ( MDI ) , perform spirometry measurement . Other protocoldefined inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>indacaterol</keyword>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>exercise endurance</keyword>
	<keyword>moderate severe chronic obstructive pulmonary disease</keyword>
	<keyword>COPD</keyword>
</DOC>